Developmental products include StrataGraft regenerative skin tissue and a technology platform for genetically enhanced skin tissues. Financial terms of the transaction were not disclosed. Stratatech's Leading-Edge, Innovative Technology Development
GEN-1 is currently being evaluated by Celsion in first line ovarian cancer patients. The Agreement will help to support supply for both ongoing and planned clinical studies in
Under the terms of the agreement, Genmab will receive an upfront payment of USD 5 million from Gilead Sciences. Genmab is entitled to potential development, regulatory and sales
The product was temporarily discontinued in April 2015 due to an issue concerning the active pharmaceutical ingredient supplier, which has been resolved. Ofloxacin otic is a quinolone antibiotic
Abeona Therapeutics president and CEO Timothy Miller said: "The addition of the EB gene therapy programs to our clinical pipeline advances our mission of serving those impacted by rare disease. "The
This single dosing regimen is in addition to the initially approved dosing regimen of 1000 mg (two 500mg vials) followed one week later by 500 mg (a single
Scintilla's lead program is resiniferatoxin ("RTX") for the treatment of intractable cancer pain. SCILEX, based in Malvern, PA, is engaged in the development and commercialization of products focused
Known as INNO2VATE, the program consists of two studies designed to evaluate vadadustat in patients with anemia related to chronic kidney disease who are undergoing dialysis. Akebia's ongoing
The milestone, which triggered an undisclosed payment from Astellas, demonstrated that selective modulation of the Unfolded Protein Response (UPR) pathway in vitro is potentially an effective disease-modifying approach
As previously announced, the Offer was accepted by shareholders holding approximately 94% of the total number of outstanding shares and votes in Meda, as of July 29, 2016.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.